These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 17587493)

  • 21. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists.
    Stahn C; Löwenberg M; Hommes DW; Buttgereit F
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):71-8. PubMed ID: 17630118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms of anti-inflammatory action of glucocorticoids.
    Cato AC; Wade E
    Bioessays; 1996 May; 18(5):371-8. PubMed ID: 8639160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Classic glucocorticoids versus non-steroidal glucocorticoid receptor modulators: survival of the fittest regulator of the immune system?
    De Bosscher K; Beck IM; Haegeman G
    Brain Behav Immun; 2010 Oct; 24(7):1035-42. PubMed ID: 20600811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [GILZ (glucocorticoid-induced leucine zipper), a mediator of the anti-inflammatory and immunosuppressive activity of glucocorticoids].
    Riccardi C
    Ann Ig; 2010; 22(1 Suppl 1):53-9. PubMed ID: 20701225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissociated glucocorticoid receptor ligands: compounds with an improved therapeutic index.
    Schäcke H; Rehwinkel H; Asadullah K
    Curr Opin Investig Drugs; 2005 May; 6(5):503-7. PubMed ID: 15912964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy.
    Tuckermann JP; Kleiman A; Moriggl R; Spanbroek R; Neumann A; Illing A; Clausen BE; Stride B; Förster I; Habenicht AJ; Reichardt HM; Tronche F; Schmid W; Schütz G
    J Clin Invest; 2007 May; 117(5):1381-90. PubMed ID: 17446934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.
    Schäcke H; Schottelius A; Döcke WD; Strehlke P; Jaroch S; Schmees N; Rehwinkel H; Hennekes H; Asadullah K
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):227-32. PubMed ID: 14694204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoid receptor in human respiratory epithelial cells.
    Pujolsa L; Mullol J; Picado C
    Neuroimmunomodulation; 2009; 16(5):290-9. PubMed ID: 19571590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms of the glucocorticoid receptor in steroid therapy - lessons from transgenic mice.
    Hübner S; Tuckermann J
    Biomol Concepts; 2012 Jun; 3(3):241-53. PubMed ID: 25436536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients with multiple sclerosis resisted to glucocorticoid therapy: abnormal expression of heat-shock protein 90 in glucocorticoid receptor complex.
    Matysiak M; Makosa B; Walczak A; Selmaj K
    Mult Scler; 2008 Aug; 14(7):919-26. PubMed ID: 18573821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of glucocorticosteroid receptors in bronchial asthma].
    Gagliardo R; Vignola AM; Bonsignore G
    Recenti Prog Med; 2001 Sep; 92(9):542-5. PubMed ID: 11552314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Action mechanism of synthetic glucocorticoids].
    Yanase T; Nawata H
    Nihon Rinsho; 1994 Mar; 52(3):578-82. PubMed ID: 8164352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting inflammation using selective glucocorticoid receptor modulators.
    De Bosscher K; Haegeman G; Elewaut D
    Curr Opin Pharmacol; 2010 Aug; 10(4):497-504. PubMed ID: 20493772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid-induced leucine zipper? A perspective.
    Ayroldi E; Macchiarulo A; Riccardi C
    FASEB J; 2014 Dec; 28(12):5055-70. PubMed ID: 25205742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calreticulin mediated glucocorticoid receptor export is involved in beta-catenin translocation and Wnt signalling inhibition in human osteoblastic cells.
    Olkku A; Mahonen A
    Bone; 2009 Apr; 44(4):555-65. PubMed ID: 19100874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety.
    Tronche F; Kellendonk C; Kretz O; Gass P; Anlag K; Orban PC; Bock R; Klein R; Schütz G
    Nat Genet; 1999 Sep; 23(1):99-103. PubMed ID: 10471508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential in vivo effects on target pathways of a novel arylpyrazole glucocorticoid receptor modulator compared with prednisolone.
    Roohk DJ; Varady KA; Turner SM; Emson CL; Gelling RW; Shankaran M; Lindwall G; Shipp LE; Scanlan TS; Wang JC; Hellerstein MK
    J Pharmacol Exp Ther; 2010 Apr; 333(1):281-9. PubMed ID: 20065017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-inflammatory functions of glucocorticoid-induced genes.
    Clark AR
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):79-97. PubMed ID: 17561338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology of glucocorticoids: beyond receptors.
    van der Laan S; Meijer OC
    Eur J Pharmacol; 2008 May; 585(2-3):483-91. PubMed ID: 18410913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy.
    Hapgood JP; Avenant C; Moliki JM
    Pharmacol Ther; 2016 Sep; 165():93-113. PubMed ID: 27288728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.